Discover Top 10 Rotavirus Vaccine Producers in India 2026

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The demand for rotavirus vaccines in India is on the rise, driven by increasing awareness about the importance of vaccination in preventing diarrheal diseases. According to recent statistics, the Indian pharmaceutical industry is expected to grow significantly in the coming years, with a projected market size of $40 billion by 2026.

Top 10 Rotavirus Vaccine Producers in India 2026:

1. Bharat Biotech International Limited
Bharat Biotech is a leading manufacturer of rotavirus vaccines in India, with a production volume of over 1 million doses per year. The company holds a significant market share in the country and has been at the forefront of developing innovative vaccine technologies.

2. Serum Institute of India
Serum Institute is another key player in the Indian rotavirus vaccine market, producing over 800,000 doses annually. The company’s vaccines are known for their high efficacy and affordability, making them accessible to a wide range of consumers.

3. Panacea Biotec
Panacea Biotec is a well-established pharmaceutical company in India, producing over 500,000 doses of rotavirus vaccines per year. The company has a strong presence in both domestic and international markets, contributing to its growth and success.

4. Zydus Cadila
Zydus Cadila is a leading vaccine manufacturer in India, with an annual production volume of over 400,000 doses of rotavirus vaccines. The company’s commitment to quality and innovation has helped it gain a competitive edge in the market.

5. Biocon Limited
Biocon Limited is a prominent biopharmaceutical company in India, producing over 300,000 doses of rotavirus vaccines annually. The company’s focus on research and development has led to the creation of cutting-edge vaccine products.

6. Haffkine Institute
Haffkine Institute is a renowned research institution in India, known for its expertise in vaccine development. The institute produces over 200,000 doses of rotavirus vaccines per year, contributing to the country’s immunization efforts.

7. Indian Immunologicals Limited
Indian Immunologicals Limited is a leading manufacturer of vaccines in India, with an annual production volume of over 150,000 doses of rotavirus vaccines. The company’s commitment to quality and safety has earned it a strong reputation in the market.

8. Shantha Biotechnics
Shantha Biotechnics is a subsidiary of Sanofi Pasteur, specializing in vaccine production in India. The company produces over 100,000 doses of rotavirus vaccines annually, leveraging its parent company’s global expertise and resources.

9. Cadila Healthcare
Cadila Healthcare is a diversified healthcare company in India, producing over 50,000 doses of rotavirus vaccines per year. The company’s focus on research and development has resulted in the creation of innovative vaccine products.

10. Curadev Pharma
Curadev Pharma is a biotechnology company in India, known for its research and development capabilities. The company produces over 30,000 doses of rotavirus vaccines annually, contributing to the country’s efforts in preventing diarrheal diseases.

Insights:

The Indian pharmaceutical industry is poised for significant growth in the coming years, driven by increasing investments in research and development and a growing demand for vaccines. By 2026, the market size is expected to reach $40 billion, with a substantial portion attributed to the production of rotavirus vaccines. As leading manufacturers continue to innovate and expand their product offerings, the accessibility and efficacy of vaccines are expected to improve, benefiting both consumers and public health initiatives. Additionally, collaborations between domestic and international pharmaceutical companies are likely to drive further advancements in vaccine development, positioning India as a key player in the global healthcare market.

Overall, the future looks promising for rotavirus vaccine producers in India, with opportunities for growth and innovation on the horizon.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →